A tumor stem cell marker DCLK1 promotes hepatocellular carcinoma by regulating β-catenin, EMT and clonogenic properties of hepatocytes

被引：0
|
作者：
Ali, Naushad
Nguyen, Charles B.
Chandrakesan, Parthasarathy
May, Randal
Dhanasekaran, Danny
Bronze, Michael S.
Houchen, Courtney W.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3884
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3884
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases
    Ali, Naushad
    Chandrakesan, Parthasarathy
    Nguyen, Charles B.
    Husain, Sanam
    Gillaspy, Allison F.
    Huycke, Mark
    Berry, William L.
    May, Randal
    Qu, Dongfeng
    Weygant, Nathaniel
    Sureban, Sripathi M.
    Bronze, Michael S.
    Dhanasekaran, Danny N.
    Houchen, Courtney W.
    ONCOTARGET, 2015, 6 (24) : 20327 - 20344
  • [32] Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells
    Carli, Annalisa L. E.
    Afshar-Sterle, Shoukat
    Rai, Alin
    Fang, Haoyun
    O'Keefe, Ryan
    Tse, Janson
    Ferguson, Fleur M.
    Gray, Nathanael S.
    Ernst, Matthias
    Greening, David W.
    Buchert, Michael
    PROTEOMICS, 2021, 21 (13-14)
  • [33] DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling
    Lianqun Zhang
    Shengli Zhou
    Ertao Guo
    Xiaoqi Chen
    Jun Yang
    Xiuling Li
    Pflügers Archiv - European Journal of Physiology, 2020, 472 : 1041 - 1049
  • [34] DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling
    Zhang, Lianqun
    Zhou, Shengli
    Guo, Ertao
    Chen, Xiaoqi
    Yang, Jun
    Li, Xiuling
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2020, 472 (08): : 1041 - 1049
  • [35] AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma
    Zhang, Jiakang
    Ren, Zhixuan
    Zheng, Dayong
    Song, Zhenghui
    Lin, Junhao
    Luo, Yue
    Zou, Xiaopei
    Pan, Yingying
    Qi, Na
    Li, Aimin
    Liu, Xinhui
    CANCERS, 2022, 14 (19)
  • [36] The short isoform of stem-cell-marker DCLK1(DCLK1-S) is strongly up-regulated during adenoma-carcinoma sequence of coloncancer disease: Role of autocrine/endocrine progastrin
    O'Connell, Malaney R.
    Sarkar, Shubhashish
    Luthra, Gurinder
    Qui, Suimin
    Gajjar, Aakash
    Maxwell, Carrie
    Singh, Pomila
    CANCER RESEARCH, 2013, 73 (08)
  • [37] Activation of hepatic stem cell marker EpCAM by Wnt-β-catenin signaling in hepatocellular carcinoma
    Yamashita, Taro
    Budhu, Anturadha
    Forgues, Marshorma
    Wang, Xin Wei
    CANCER RESEARCH, 2007, 67 (22) : 10831 - 10839
  • [38] DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner
    Sepideh Razi
    Asieh Sadeghi
    Zeynab Asadi-Lari
    Kevin J. Tam
    Elham Kalantari
    Zahra Madjd
    Clinical and Experimental Medicine, 2021, 21 : 139 - 147
  • [39] DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner
    Razi, Sepideh
    Sadeghi, Asieh
    Asadi-Lari, Zeynab
    Tam, Kevin J.
    Kalantari, Elham
    Madjd, Zahra
    CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (01) : 139 - 147
  • [40] Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods
    Mirzaei, Alireza
    Madjd, Zahra
    Kadijani, Azade Amini
    Tavakoli-Yaraki, Masoumeh
    Modarresi, Mohammad Hossein
    Verdi, Javad
    Akbari, Abolfazl
    Tavoosidana, Gholamreza
    CANCER BIOMARKERS, 2016, 17 (03) : 301 - 311
12345